ANTX Insider Transactions
245 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
ANTX insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Readnour Robin Shane | Director | 2026-08-17 | Sale | 18,706 | $6.0082 |
| Readnour Robin Shane | Director | 2026-08-17 | Sale | 16,696 | $6.0082 |
| Eizen Joshua M | See Remarks | 2026-07-08 | Sale | 5,945 | $4.172 |
| Williams Sarah Joanne | Principal Accounting Officer | 2026-05-29 | Sale | 265.0 | $4.43 |
| Williams Sarah Joanne | Principal Accounting Officer | 2026-03-03 | Sale | 327.0 | $1.06 |
| Day Lucy | Chief Financial Officer | 2026-01-06 | Sale | 5,512.0 | $1.01 |
| Prior Stephen David | Chief Strategy Officer | 2026-01-06 | Sale | 2,858.0 | $1.01 |
| Chanda Sanjay | Chief Development Officer | 2026-01-06 | Sale | 5,956.0 | $1.01 |
| Eizen Joshua M | See Remarks | 2026-01-06 | Sale | 6,931.0 | $1.01 |
| Day Lucy | Chief Financial Officer | 2026-01-05 | Sale | 3,295.0 | $1.0 |
| Prior Stephen David | Chief Strategy Officer | 2026-01-05 | Sale | 3,604.0 | $1.0 |
| Chanda Sanjay | Chief Development Officer | 2026-01-05 | Sale | 3,295.0 | $1.0 |
| Eizen Joshua M | See Remarks | 2026-01-05 | Sale | 17,923.0 | $1.0 |
| Eizen Joshua M | See Remarks | 2025-11-04 | Sale | 2,819.0 | $1.14 |
| Prior Stephen David | Chief Strategy Officer | 2025-11-04 | Sale | 765.0 | $1.14 |
| Easom Eric | Chief Executive Officer | 2025-06-02 | Purchase | 10,000.0 | $1.07 |
| Leonard Braden Michael | TenPercentOwner | 2025-05-30 | Sale | 7,000.0 | $1.03 |
| Leonard Braden Michael | TenPercentOwner | 2025-05-30 | Sale | 425,000.0 | $1.01 |
| Leonard Braden Michael | TenPercentOwner | 2025-05-28 | Sale | 200,000.0 | $1.09 |
| Leonard Braden Michael | TenPercentOwner | 2025-05-28 | Sale | 100,000.0 | $1.16 |
| Leonard Braden Michael | TenPercentOwner | 2025-05-28 | Sale | 2,000,000.0 | $1.16 |
| FitzPatrick Margaret M | Director | 2025-05-28 | Purchase | 8,610.0 | $1.18 |
| Day Lucy | Chief Financial Officer | 2025-01-03 | Sale | 2,957.0 | $1.34 |
| Chanda Sanjay | Chief Development Officer | 2025-01-03 | Sale | 2,957.0 | $1.34 |
| Prior Stephen David | Chief Strategy Officer | 2025-01-03 | Sale | 2,029.0 | $1.34 |
| Eizen Joshua M | See Remarks | 2025-01-03 | Sale | 9,663.0 | $1.34 |
| Readnour Robin Shane | Director | 2024-12-10 | Purchase | 5,000.0 | $1.49 |
| Readnour Robin Shane | Director | 2024-12-10 | Purchase | 5,000.0 | $1.49 |
| Readnour Robin Shane | Director | 2024-12-09 | Purchase | 18,483.0 | $1.43 |
| Readnour Robin Shane | Director | 2024-12-09 | Purchase | 12,289.0 | $1.43 |
| Readnour Robin Shane | Director | 2024-12-06 | Purchase | 6,517.0 | $1.45 |
| Readnour Robin Shane | Director | 2024-12-06 | Purchase | 12,711.0 | $1.45 |
| Readnour Robin Shane | Director | 2024-11-27 | Purchase | 25,000.0 | $1.42 |
| Readnour Robin Shane | Director | 2024-11-27 | Purchase | 25,000.0 | $1.42 |
| Zakrzewski Joseph S | Director | 2024-11-27 | Purchase | 2,000.0 | $1.4 |
| Readnour Robin Shane | Director | 2024-11-26 | Purchase | 12,500.0 | $1.39 |
| Readnour Robin Shane | Director | 2024-11-26 | Purchase | 12,500.0 | $1.39 |
| Readnour Robin Shane | Director | 2024-11-20 | Purchase | 25,000.0 | $1.15 |
| Readnour Robin Shane | Director | 2024-11-20 | Purchase | 25,000.0 | $1.16 |
| Readnour Robin Shane | Director | 2024-11-19 | Purchase | 75,000.0 | $1.04 |
| Readnour Robin Shane | Director | 2024-11-19 | Purchase | 75,000.0 | $1.03 |
| Zakrzewski Joseph S | Director | 2024-11-19 | Purchase | 5,000.0 | $1.01 |
| Zakrzewski Joseph S | Director | 2024-11-18 | Purchase | 20,000.0 | $1.0 |
| Easom Eric | Chief Executive Officer | 2024-11-18 | Purchase | 50,000.0 | $1.0 |
| Leonard Braden Michael | TenPercentOwner | 2024-08-14 | Purchase | 1,500,000.0 | $1.04 |
| RA Capital Healthcare Fund LP | TenPercentOwner | 2024-08-09 | Sale | 114,759.0 | $1.08 |
| RA CAPITAL MANAGEMENT, L.P. | TenPercentOwner | 2024-08-09 | Sale | 114,759.0 | $1.08 |
| Kolchinsky Peter | TenPercentOwner | 2024-08-09 | Sale | 114,759.0 | $1.08 |
| Shah Rajeev M. | TenPercentOwner | 2024-08-09 | Sale | 114,759.0 | $1.08 |
| RA Capital Nexus Fund II, L.P. | TenPercentOwner | 2024-08-09 | Sale | 114,759.0 | $1.08 |
| RA Capital Healthcare Fund LP | TenPercentOwner | 2024-08-09 | Sale | 3,410,335.0 | $1.08 |
| RA CAPITAL MANAGEMENT, L.P. | TenPercentOwner | 2024-08-09 | Sale | 3,410,335.0 | $1.08 |
| Kolchinsky Peter | TenPercentOwner | 2024-08-09 | Sale | 3,410,335.0 | $1.08 |
| Shah Rajeev M. | TenPercentOwner | 2024-08-09 | Sale | 3,410,335.0 | $1.08 |
| RA Capital Nexus Fund II, L.P. | TenPercentOwner | 2024-08-09 | Sale | 3,410,335.0 | $1.08 |
| Zakrzewski Joseph S | Director | 2024-01-18 | Sale | 100,000.0 | $19.11 |
| Aziz Kabeer | Director | 2024-01-16 | Sale | 15,907.0 | $19.65 |
| Aziz Kabeer | Director | 2024-01-16 | Sale | 84,093.0 | $19.65 |
| Adjuvant Global Health Technology Fund, L.P. | TenPercentOwner | 2024-01-16 | Sale | 15,907.0 | $19.65 |
| Adjuvant Global Health Technology Fund DE, L.P. | TenPercentOwner | 2024-01-16 | Sale | 15,907.0 | $19.65 |
| Adjuvant Capital Management, LLC | TenPercentOwner | 2024-01-16 | Sale | 15,907.0 | $19.65 |
| Adjuvant Capital GP, L.P. | TenPercentOwner | 2024-01-16 | Sale | 15,907.0 | $19.65 |
| Adjuvant Global Health Technology Fund, L.P. | TenPercentOwner | 2024-01-16 | Sale | 84,093.0 | $19.65 |
| Adjuvant Global Health Technology Fund DE, L.P. | TenPercentOwner | 2024-01-16 | Sale | 84,093.0 | $19.65 |
| Adjuvant Capital Management, LLC | TenPercentOwner | 2024-01-16 | Sale | 84,093.0 | $19.65 |
| Adjuvant Capital GP, L.P. | TenPercentOwner | 2024-01-16 | Sale | 84,093.0 | $19.65 |
| Readnour Robin Shane | Director | 2024-01-12 | Sale | 719.0 | $21.91 |
| Readnour Robin Shane | Director | 2024-01-12 | Sale | 706.0 | $21.92 |
| Readnour Robin Shane | Director | 2024-01-10 | Sale | 1,800.0 | $21.92 |
| Readnour Robin Shane | Director | 2024-01-10 | Sale | 1,869.0 | $21.93 |
| Krause Kevin Michael | Chief Strategy Officer | 2024-01-09 | Sale | 7,417.0 | $20.14 |
| Krause Kevin Michael | Chief Strategy Officer | 2024-01-02 | Sale | 2,583.0 | $20.12 |
| Easom Eric | Chief Executive Officer | 2024-01-02 | Sale | 2,777.0 | $20.09 |
| Adjuvant Global Health Technology Fund, L.P. | TenPercentOwner | 2023-11-14 | Sale | 288.0 | $16.15 |
| Adjuvant Global Health Technology Fund DE, L.P. | TenPercentOwner | 2023-11-14 | Sale | 288.0 | $16.15 |
| Adjuvant Capital Management, LLC | TenPercentOwner | 2023-11-14 | Sale | 288.0 | $16.15 |
| Adjuvant Capital GP, L.P. | TenPercentOwner | 2023-11-14 | Sale | 288.0 | $16.15 |
| Adjuvant Global Health Technology Fund, L.P. | TenPercentOwner | 2023-11-14 | Sale | 1,522.0 | $16.15 |
| Adjuvant Global Health Technology Fund DE, L.P. | TenPercentOwner | 2023-11-14 | Sale | 1,522.0 | $16.15 |
| Adjuvant Capital Management, LLC | TenPercentOwner | 2023-11-14 | Sale | 1,522.0 | $16.15 |
| Adjuvant Capital GP, L.P. | TenPercentOwner | 2023-11-14 | Sale | 1,522.0 | $16.15 |
| Aziz Kabeer | Director,TenPercentOwner | 2023-11-14 | Sale | 288.0 | $16.15 |
| Aziz Kabeer | Director,TenPercentOwner | 2023-11-14 | Sale | 1,522.0 | $16.15 |
| Aziz Kabeer | Director,TenPercentOwner | 2023-10-02 | Sale | 902.0 | $16.07 |
| Aziz Kabeer | Director,TenPercentOwner | 2023-10-02 | Sale | 4,770.0 | $16.07 |
| Adjuvant Global Health Technology Fund, L.P. | TenPercentOwner | 2023-10-02 | Sale | 902.0 | $16.07 |
| Adjuvant Global Health Technology Fund DE, L.P. | TenPercentOwner | 2023-10-02 | Sale | 902.0 | $16.07 |
| Adjuvant Capital Management, LLC | TenPercentOwner | 2023-10-02 | Sale | 902.0 | $16.07 |
| Adjuvant Capital GP, L.P. | TenPercentOwner | 2023-10-02 | Sale | 902.0 | $16.07 |
| Adjuvant Global Health Technology Fund, L.P. | TenPercentOwner | 2023-10-02 | Sale | 4,770.0 | $16.07 |
| Adjuvant Global Health Technology Fund DE, L.P. | TenPercentOwner | 2023-10-02 | Sale | 4,770.0 | $16.07 |
| Adjuvant Capital Management, LLC | TenPercentOwner | 2023-10-02 | Sale | 4,770.0 | $16.07 |
| Adjuvant Capital GP, L.P. | TenPercentOwner | 2023-10-02 | Sale | 4,770.0 | $16.07 |
| Aziz Kabeer | Director,TenPercentOwner | 2023-09-29 | Sale | 15,764.0 | $16.28 |
| Aziz Kabeer | Director,TenPercentOwner | 2023-09-29 | Sale | 83,337.0 | $16.28 |
| Adjuvant Global Health Technology Fund, L.P. | TenPercentOwner | 2023-09-29 | Sale | 15,764.0 | $16.28 |
| Adjuvant Global Health Technology Fund DE, L.P. | TenPercentOwner | 2023-09-29 | Sale | 15,764.0 | $16.28 |
| Adjuvant Capital Management, LLC | TenPercentOwner | 2023-09-29 | Sale | 15,764.0 | $16.28 |
| Adjuvant Capital GP, L.P. | TenPercentOwner | 2023-09-29 | Sale | 15,764.0 | $16.28 |
| Adjuvant Global Health Technology Fund, L.P. | TenPercentOwner | 2023-09-29 | Sale | 83,337.0 | $16.28 |